- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02875756
Effect of the Number of Needle Revolutions Inside the Node on the Diagnostic Yield of EBUS-TBNA in Sarcoidosis
A Study Evaluating the Effect of the Number of Needle Revolutions Inside the Node on the Diagnostic Yield of EBUS-TBNA in Sarcoidosis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Sarcoidosis is a multisystem disorder of unknown etiology characterized by granulomatous inflammation involving various body organs. The diagnosis is made on the basis of compatible clinicoradiological feature, histopathologic evidence of non-caseating granuloma, and exclusion of other known causes for granulomatous inflammation. As the lung and mediastinal lymph nodes are the most commonly involved structures in sarcoidosis, various bronchoscopic techniques like endobronchial biopsy (EBB), transbronchial biopsy (TBLB) and transbronchial needle aspiration (TBNA) are needed for tissue sampling.
Among the bronchoscopic techniques, TBNA of lymph nodes has emerged as the most useful modality in addition to the previously known endobronchial and transbronchial biopsies. The efficacy and safety of conventional TBNA are well established. With improvements in technology, last decade has seen the use of EBUS to guide transbronchial needle aspiration. This technique is a minimally invasive and offers the additional advantage of choosing the appropriate node for sampling based on the vascularity, echogenicity and size. Studies subsequently have demonstrated the superiority EBUS-TBNA over conventional TBNA.
Once the role of TBNA in diagnostic bronchoscopy was clear, technical aspects of the procedure became the topic of research. This includes the number of aspirations or passes required per lymph node station, needle gauge (21 vs. 22 gauge), suction pressure, and the distance travelled by the needle within the lymph node. The number of revolutions i.e. the number of times the needle should be moved back-and-forth inside the lymph node is one such factor. The recommendation is to move the needle ten to twenty times. However the optimum number of times the needle should be moved back and forth for extracting adequate tissue material has not been studied to date. The investigators have observed that performing revolutions during EBUS-TBNA frequently leads to aspiration of blood during the procedure.
The investigators hypothesize that the number of revolutions will not affect the diagnostic yield, and the yield would be similar in 10 compared to 20 revolutions. In this study, the investigators plan to evaluate the effect of the number of needle revolutions inside the node on the diagnostic yield of EBUS-TBNA in patients with sarcoidosis.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
UT
-
Chandigarh, UT, India, 160012
- Post Graduate Institute of Medical Education and Research
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age group of 18 to 65 years
- Clinicoradiological suspicion of sarcoidosis where EBUS-TBNA is being planned
- Enlarged hilar and mediastinal lymph nodes >10 mm (any axis) on computed tomography of the chest
Exclusion Criteria:
- Hypoxemia (SpO2 <92% on FiO2 of 0.3)
- Treatment with systemic glucocorticoids for >2 weeks in the preceding three months
- Diagnosis of sarcoidosis possible with another minimally invasive technique such as skin biopsy or peripheral lymph node biopsy
- Failure to provide informed consent.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 10 revolutions
In this group, 10 revolutions will be made with the EBUS-TBNA needle
|
The 22G needle (Vizishot, Olympus) will be used to obtain specimens from the enlarged lymph nodes during EBUS.
Once inside the lymph node, needle will be passed to and fro 10 times
|
|
Active Comparator: 20 revolutions
In this group, 10 revolutions will be made with the EBUS-TBNA needle
|
The 22G needle (Vizishot, Olympus) will be used to obtain specimens from the enlarged lymph nodes during EBUS.
Once inside the lymph node, needle will be passed to and fro 20 times
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Diagnostic yield of EBUS-TBNA as indicated by the presence of granuloma
Time Frame: 1 week
|
1 week
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Adequacy of samples as indicated by the presence of lymphocytes
Time Frame: 1 week
|
1 week
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NK/2232/study/1116
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sarcoidosis
-
Mayo ClinicNot yet recruitingCardiac Sarcoidosis | Sarcoidosis, Cardiac | Sarcoidosis With Myocarditis | Sarcoidosis of the HeartUnited States
-
Celularity IncorporatedTerminatedStage 2 Pulmonary Sarcoidosis | Stage 3 Pulmonary SarcoidosisUnited States
-
Vanderbilt UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedSarcoidosis; Antimycobacterial TherapyUnited States
-
Duke UniversityFoundation for Sarcoidosis ResearchRecruiting
-
Sanjay Gandhi Postgraduate Institute of Medical...RecruitingSarcoidosis Lung | Pulmonary SarcoidosisIndia
-
Alexandria UniversityCompletedEndobronchial Mucosal Pathology in Pulmonary SarcoidosisEgypt
-
Heart Center Leipzig - University HospitalRecruiting
-
British Columbia Cancer AgencyApproved for marketing
-
University of Maryland, BaltimoreMallinckrodtCompleted
-
University of PennsylvaniaAdvanced Accelerator ApplicationsCompleted
Clinical Trials on 10 revolutions
-
Ministry of Health and Population, EgyptCompletedPainful Diabetic NeuropathyEgypt
-
West China HospitalRecruitingAdvanced Solid Tumors | NeoplasmChina
-
West China HospitalRecruitingHPV-positive Oropharyngeal Squamous Cell CarcinomaChina
-
Jas ChahalCompleted
-
BNM Clinic and ResearchCompletedDental Restoration, Permanent
-
Provectus Biopharmaceuticals, Inc.No longer availableCutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory | Approved Alternative TherapyUnited States, Australia
-
Provectus PharmaceuticalsCompleted
-
Provectus PharmaceuticalsCompleted
-
AerasEuropean and Developing Countries Clinical Trials Partnership (EDCTP)Completed
-
Merry, Graham, M.D.CompletedNonexudative Age-related Macular DegenerationUnited States, Canada